Omnicell Inc (OMCL)

43.20
NASDAQ : Technology
Prev Close 43.15
Day Low/High 42.85 / 43.80
52 Wk Low/High 30.35 / 44.60
Avg Volume 214.20K
Exchange NASDAQ
Shares Outstanding 37.16M
Market Cap 1.60B
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Omnicell Showcases Portfolio Of Award-Winning Medication Management Solutions At Annual ASHP Summer Meeting

Matthew J. Kelm, Associate Chief Pharmacy Officer at Duke University Hospital, Hosts Q&A Session on Delivering Safer, More Efficient Ways to Manage Medications

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ATRO, BLL, CCE, CSII, EGN, EMR, HCI, IMPV, K, MANT, MLCO, MX, OI, RDS.A, RDS.B, TPRE, USCR, WMC Downgrades: CCO, CLF, GCAP, INCY, KMPR, OMCL, OMI, SHEN, SWIR, UEPS Initiations: ORMP Read on to get TheStreet Quant Ratings' detailed report:

Southcoast Health Selects Omnicell's Medication Management And Analytics Solutions For Installation Across Multiple Facilities

Health System to Implement Medication Dispensing Solutions, Performance Center, and IV Automation

Omnicell Announces Launch Of XT Cabinets For AcuDose-Rx Customers

Newest Solutions Available Earlier than Anticipated

North Memorial Health Selects Omnicell's Medication Management Solutions To Support Increased Safety And Efficiency Throughout The Hospital

New Technology Will Span from Central Pharmacy to Hospital Floors and Operating Rooms

Omnicell Acquires InPharmics

Advanced Pharmacy Informatics Capabilities Enhance Performance Center Offering

Omnicell Medication Adherence Named A 50+ Innovation Leader

Inaugural Initiative of AARP and MedCity News Showcases Companies and People Delivering Cutting-Edge Healthcare Solutions for the 50+ Market

Short Interest In Omnicell Increases 15.6%

The most recent short interest data has been released for the 03/15/2017 settlement date, which shows a 538,618 share increase in total short interest for Omnicell Inc , to 3,984,297, an increase of 15.63% since 02/28/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Omnicell's Newest Automated Dispensing Solutions To Be Showcased At The European Association Of Hospital Pharmacists Congress

XT Series Cabinets, IV Compounding Technology and Analytics Solutions Featured in Stand 49

Omnicell Supports Pharmacy Advancement Through Unrestricted Grant

Company Partners with EAHP to Increase Patient Safety

Inova Partners With Omnicell To Enhance Pharmacy Supply Chain Strategy

Performance Center Software and Services Offering Drives Medication Cost Savings

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ALKS, CCU, CRAY, CRNT, DX, ELMD, ESSA, NLY, OMCL, XEC Downgrades: ETR, RDCM Initiations: SGLB Read on to get TheStreet Quant Ratings' detailed report:

Omnicell Launches Innovative Medication Adherence Automated Pharmacy Solution to Increase Pharmacy Efficiency and Profitability

Omnicell VBM 200F fills and checks SureMed multiple medication blister cards

Omnicell Medication Management Solutions And Interoperability Featured At HIMSS17 With Real World Application In Interoperability Showcase

Combination of Hardware, Technology, and Professional Services in Booth #4009 Demonstrates How Hospitals Can Help Improve Clinical and Financial Performance

DCH Health System Partners With Omnicell To Automate Sterile Compounding With Robotic IV Insourcing Solution (RIIS)

Comprehensive, turnkey solution supports safer and more cost-effective compounding

Omnicell Stock Sees Short Interest Increase 12.2%

The most recent short interest data has been released for the 01/31/2017 settlement date, which shows a 277,900 share increase in total short interest for Omnicell Inc , to 2,555,167, an increase of 12.20% since 01/13/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AXE, CECE, EMN, FC, NNI, PDCO, SAH, SAMG, WERN Downgrades: ATW, CERN, IPXL, NVO, OMCL, PHII, PHIIK, PLKI, SVT Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Omnicell Stock Sees Short Interest Decrease By 20.2%

Omnicell Stock Sees Short Interest Decrease By 20.2%

The most recent short interest data has been released for the 07/29/2016 settlement date, which shows a 314,564 share decrease in total short interest for Omnicell Inc , to 1,243,238, a decrease of 20.19% since 07/15/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Insider Trading Alert - XPLR, ACET And OMCL Traded By Insiders

Insider Trading Alert - XPLR, ACET And OMCL Traded By Insiders

Stocks with insider trader activity include XPLR, ACET and OMCL

These Small-Cap Growth Stocks Look Ready to Pop

These Small-Cap Growth Stocks Look Ready to Pop

Four small-cap growth companies look like they're on sale now.

Insider Trading Alert - SON, GES And OMCL Traded By Insiders

Insider Trading Alert - SON, GES And OMCL Traded By Insiders

Stocks with insider trader activity include SON, GES and OMCL

RBC Capital Markets Likes These 13 Small-Cap Stocks for Your 2016 Portfolio

RBC Capital Markets Likes These 13 Small-Cap Stocks for Your 2016 Portfolio

Since this summer's market low, small-cap stocks have been outperforming large-cap stocks. Here are small caps with 'persistently strong top-line growth and improving fundamentals,' according to RBC Capital Markets.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ALB, CUB, DLTR, FRO, GIG, HWBK, KZ, OFS, OMCL, RGS, TEDU Downgrades: ARC, ENTA, NX, SDRL Initiations: MELR Read on to get TheStreet Quant Ratings' detailed report:

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BOCH, HHC, HMIN, PLCM, PRIM, QLYS, RUBI, SFST, SPTN Downgrades: CCO, CDI, DCO, DIOD, FSTR, IBM, ICON, LIOX, OMCL, QUAD, SAVE, STWD, TIME, VET, VNDA Initiations: HUBS, OMAM, OPHT, OSGB, VBTX Read on to get TheStreet Quant Ratings' detailed report:

Omnicell is Now Oversold (OMCL)

Omnicell is Now Oversold (OMCL)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Insider Trading Alert - CVGW, OMCL And LLY Traded By Insiders

Insider Trading Alert - CVGW, OMCL And LLY Traded By Insiders

Stocks with insider trader activity include CVGW, OMCL and LLY